Cite
HARVARD Citation
Conteduca, V. et al. (2017). Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer. Scientific reports. 7 (1), pp. 1-9. [Online].